Severe strongyloidiasis: a systematic review and meta-analysis of 339 cases

Trans R Soc Trop Med Hyg. 2023 Oct 3;117(10):682-696. doi: 10.1093/trstmh/trad032.

Abstract

Strongyloidiasis is a parasitosis representing a significant public health problem in tropical countries. It is often asymptomatic in immunocompetent individuals but its mortality rate increases to approximately 87% in severe forms of the disease. We conducted a systematic review, including case reports and case series, of Strongyloides hyperinfection and dissemination from 1998 to 2020 searching PubMed, EBSCO and SciELO. Cases that met the inclusion criteria of the Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist were analysed. Statistical analysis was performed using Fisher's exact test and Student's t-test and a Bonferroni correction for all the significant values. A total of 339 cases were included in this review. The mortality rate was 44.83%. The presence of infectious complications, septic shock and a lack of treatment were risk factors for a fatal outcome. Eosinophilia and ivermectin treatment were associated with an improved outcome.

Keywords: Strongyloides; opportunistic infection; parasitology; strongyloidiasis; superinfection; systematic review.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Animals
  • Humans
  • Ivermectin / therapeutic use
  • Strongyloides stercoralis*
  • Strongyloidiasis* / drug therapy
  • Strongyloidiasis* / epidemiology
  • Superinfection* / complications

Substances

  • Ivermectin